Pacific Biosciences of California (PACB) News Today $1.97 +0.04 (+2.07%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Fmr LLC Raises Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Fmr LLC increased its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 641.3% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 408,151 shares of the biotechnology company's stock after buying an additDecember 18 at 3:11 AM | marketbeat.comWhy Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short SellersDecember 11, 2024 | msn.comBNP Paribas Financial Markets Has $1.13 Million Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB)BNP Paribas Financial Markets lowered its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 34.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 662,728 shares of the biotechnology company's stock after selling 341,387 shaDecember 11, 2024 | marketbeat.comPacific Biosciences Appoints CEO as Interim CFODecember 6, 2024 | tipranks.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Up - What's Next?Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up - Still a Buy?December 6, 2024 | marketbeat.comSoros Fund Management LLC Raises Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Soros Fund Management LLC raised its stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 23.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2December 6, 2024 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Rating of "Hold" by AnalystsShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have earned an average recommendation of "Hold" from the fifteen research firms that are presently covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a hold rating and seven hDecember 4, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Trading 7.4% Higher - Time to Buy?Pacific Biosciences of California (NASDAQ:PACB) Shares Up 7.4% - What's Next?November 29, 2024 | marketbeat.comSOFTBANK GROUP CORP. Acquires Significant Stake in Pacific Biosciences of California IncNovember 26, 2024 | gurufocus.comSenvest Management LLC Has $1.86 Million Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Senvest Management LLC grew its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 36.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,093,9November 24, 2024 | marketbeat.comPacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right NowNovember 20, 2024 | msn.comDeciphering Disruption: Inside Cathie Wood's Latest Plays (PACB)Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.November 18, 2024 | marketbeat.comSumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Sumitomo Mitsui Trust Group Inc. lessened its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 6.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,865,766 shares of the biotechnolNovember 18, 2024 | marketbeat.comFY2024 EPS Estimates for PACB Lowered by Cantor FitzgeraldPacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2024 EPS estimates for Pacific Biosciences of California in a report released on Wednesday, November 13th. Cantor Fitzgerald analyst R. Osborn now anticipates that theNovember 18, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by UBS GroupUBS Group upgraded Pacific Biosciences of California to a "hold" rating in a report on Sunday.November 14, 2024 | marketbeat.comPacific Biosciences' Cost Cuts Won't Offset Rising CompetitionNovember 12, 2024 | seekingalpha.comPacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 12, 2024 | finance.yahoo.comCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtNovember 12, 2024 | fool.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.3% After Analyst UpgradePacific Biosciences of California (NASDAQ:PACB) Trading Up 5.3% on Analyst UpgradeNovember 12, 2024 | marketbeat.comUBS Downgrades Pacific Biosciences of California (PACB)November 12, 2024 | msn.comScotiabank Keeps Their Buy Rating on Pacific Biosciences (PACB)November 12, 2024 | markets.businessinsider.comScotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $6.00Scotiabank lowered their target price on Pacific Biosciences of California from $7.00 to $6.00 and set a "sector outperform" rating on the stock in a research report on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California Target of Unusually High Options Trading (NASDAQ:PACB)Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) saw unusually large options trading on Monday. Investors purchased 10,101 call options on the stock. This represents an increase of 271% compared to the average daily volume of 2,719 call options.November 11, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Rating Lowered to "Neutral" at UBS GroupUBS Group cut Pacific Biosciences of California from a "buy" rating to a "neutral" rating in a research note on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Given New $2.50 Price Target at Piper SandlerPiper Sandler raised their target price on Pacific Biosciences of California from $2.00 to $2.50 and gave the company a "neutral" rating in a research note on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendatNovember 9, 2024 | marketbeat.comBarclays Reaffirms Their Hold Rating on Pacific Biosciences (PACB)November 8, 2024 | markets.businessinsider.comPacBio to Present at Upcoming Investor ConferencesNovember 8, 2024 | globenewswire.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - What's Next?Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Should You Sell?November 8, 2024 | marketbeat.comPacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ...November 8, 2024 | finance.yahoo.comPacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comTD Cowen Keeps Their Buy Rating on Pacific Biosciences (PACB)November 7, 2024 | markets.businessinsider.comPacific Biosciences of California, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comPacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028November 7, 2024 | globenewswire.comPacific Biosciences of California Inc (PACB) Q3 2024 Earnings Report Preview: What To ExpectNovember 7, 2024 | finance.yahoo.comPacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the BenchtopNovember 6, 2024 | globenewswire.comAssenagon Asset Management S.A. Trims Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Assenagon Asset Management S.A. cut its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 78.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 281,887 shares of theNovember 4, 2024 | marketbeat.comPacific Biosciences of California (PACB) to Release Quarterly Earnings on ThursdayPacific Biosciences of California (NASDAQ:PACB) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634755)October 31, 2024 | marketbeat.comPacific Biosciences (PACB): Promising Gene Editing Stock With Innovating TechnologyOctober 30, 2024 | msn.comVolta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prepOctober 30, 2024 | prnewswire.comPacBio announces SPRQ chemistry for Revio sequencing systemsOctober 30, 2024 | markets.businessinsider.comPacific Biosciences of California, Inc. (NASDAQ:PACB) is a favorite amongst institutional investors who own 86%October 30, 2024 | finance.yahoo.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.7% - Still a Buy?Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.7% - Here's WhyOctober 29, 2024 | marketbeat.comPacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500October 29, 2024 | globenewswire.comPacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner ProgramOctober 22, 2024 | globenewswire.comPacific Biosciences of California (NASDAQ:PACB) Shares Down 4.8% - Should You Sell?Pacific Biosciences of California (NASDAQ:PACB) Shares Down 4.8% - Here's WhyOctober 16, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Here's What HappenedPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Here's What HappenedOctober 14, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 2,121,331 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)Dimensional Fund Advisors LP lowered its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 61.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,313,137 shares of the biotechnology company'October 12, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 18.4% - Here's WhyPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 18.4% - Here's WhyOctober 11, 2024 | marketbeat.com Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now PACB Media Mentions By Week PACB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PACB News Sentiment▼0.760.60▲Average Medical News Sentiment PACB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PACB Articles This Week▼14▲PACB Articles Average Week Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HBIO News Today TMO News Today A News Today MTD News Today ILMN News Today WAT News Today TECH News Today CRL News Today BIO News Today BRKR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PACB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PACB Stock Alerts